You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. ANBIO BIOTECHNOLOGY - ORDINARY SHARES - CLASS A

Anbio Biotechnology - Ordinary Shares - Class A XNAS: NNNN

Anbio Biotechnology - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Download real time

7.49 0.32 (4.46%)

New 52W High in past week

285.3K XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
3.3 / 100
Momentum Score
Technically Bearish
9.6 / 100
Analyst Price Target
No estimates available

9

S

5

W

0

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

Not enough data available


Anbio Biotechnology - Ordi... Live Price Chart

Switch to TradingView
Fetching data ...

Anbio Biotechnology - Ordi... Stock Analysis

Anbio Biotechnology - Ordi... stock analysis with key metrics, changes, and trends.

Anbio Biotechnology - Ordi... MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$6.71 M71.49%negative

Annual Revenue fell 71.49%, in the last year to $6.71 M. Its sector's average revenue growth for the last fiscal year was 23.17%.

Annual Net Profit$2.25 M77.49%negative

Annual Net Profit fell 77.49% in the last year to $2.25 M. Its sector's average net profit growth for the last fiscal year was -0.84%.

Stock Price$7.4912.13%positive

Stock Price rose 12.13% outperformed its sector by 8.61% in the past week.

Return on Equity(ROE)16.47 %16.47%neutral

Return on Equity(ROE) for the last financial year was 16.47%, in the normal range of 10% to 20%.



Loading data..

Anbio Biotechnology - Ordinary Shares - Class A - Company Profile

What does Anbio Biotechnology - Ordinary Shares - Class A do?

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. IVD products are designed to detect a wide range of biomarkers associated with critical medical domains. Its research and development activities for all IVD products: Biomarker Discovery and Validation, Assay Development, Validation - Clinical and Analytical and Platform Transfer. Its product AF-1200 Fluorescence Immunoassay Analyzer, AF-100 Fluorescence Immunoassay Analyzer, AF-100S Fluorescence Immunoassay Analyzer, AF-100C Fluorescence Immunoassay Analyzer.

Anbio Biotechnology - Ordinary Shares - Class A FAQ

How is Anbio Biotechnology - Ordinary Shares - Class A today?
Anbio Biotechnology - Ordinary Shares - Class A today is trading in the green, and is up by 4.46% at 7.49.
Anbio Biotechnology - Ordinary Shares - Class A is currently trading up 4.46% on an intraday basis. In the past week the stock rose 12.13%. stock has been down None% in the past quarter and fell None% in the past year. You can view this in the overview section.